Association between Rates of Visual Field Progression and Intraocular Pressure Measurements Obtained by Different Tonometers.
Aged
Aged, 80 and over
Cohort Studies
Disease Progression
Female
Follow-Up Studies
Glaucoma, Open-Angle
/ physiopathology
Gonioscopy
Humans
Intraocular Pressure
/ physiology
Male
Middle Aged
Prospective Studies
Slit Lamp Microscopy
Tonometry, Ocular
/ instrumentation
Vision Disorders
/ diagnosis
Visual Acuity
/ physiology
Visual Field Tests
Visual Fields
/ physiology
Journal
Ophthalmology
ISSN: 1549-4713
Titre abrégé: Ophthalmology
Pays: United States
ID NLM: 7802443
Informations de publication
Date de publication:
01 2019
01 2019
Historique:
received:
27
03
2018
revised:
15
07
2018
accepted:
31
07
2018
pubmed:
17
8
2018
medline:
19
10
2019
entrez:
17
8
2018
Statut:
ppublish
Résumé
To investigate the associations between intraocular pressure (IOP) measurements obtained by different tonometric methods and rates of visual field loss in a cohort of patients with glaucoma followed over time. Prospective, observational cohort study. This study included 213 eyes of 125 glaucomatous patients who were followed for an average of 2.4±0.6 years. At each visit, IOP measurements were obtained using Goldmann applanation tonometry (GAT), the Ocular Response Analyzer (ORA) (Reichert, Inc., Depew, NY), corneal-compensated IOP (IOP Strength of associations (R Average values for mean IOP over time measured by GAT, ORA, and RBT were 14.4±3.3, 15.2±4.2, and 13.4±4.2 mmHg, respectively. Mean IOP Mean ORA IOP
Identifiants
pubmed: 30114419
pii: S0161-6420(18)30843-1
doi: 10.1016/j.ophtha.2018.07.031
pmc: PMC6882426
mid: NIHMS993224
pii:
doi:
Types de publication
Comparative Study
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
49-54Subventions
Organisme : NEI NIH HHS
ID : R01 EY021818
Pays : United States
Informations de copyright
Copyright © 2018 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.
Références
J Glaucoma. 2008 Sep;17(6):442-8
pubmed: 18794677
Ophthalmology. 2013 Aug;120(8):1533-40
pubmed: 23642371
Invest Ophthalmol Vis Sci. 2009 May;50(5):2224-9
pubmed: 19151396
Am J Ophthalmol. 2000 Oct;130(4):429-40
pubmed: 11024415
Ophthalmology. 2007 Nov;114(11):1965-72
pubmed: 17628686
Am J Ophthalmol. 2016 Jun;166:29-36
pubmed: 26949135
Arch Ophthalmol. 2002 Jun;120(6):714-20; discussion 829-30
pubmed: 12049575
Invest Ophthalmol Vis Sci. 2005 Nov;46(11):4189-99
pubmed: 16249498
JAMA. 2014 May 14;311(18):1901-11
pubmed: 24825645
Prog Retin Eye Res. 2005 Jan;24(1):39-73
pubmed: 15555526
Ophthalmologica. 1957 Oct;134(4):221-42
pubmed: 13484216
Invest Ophthalmol Vis Sci. 2008 Sep;49(9):3919-26
pubmed: 18539936
Invest Ophthalmol Vis Sci. 2015 Mar 03;56(3):2031-42
pubmed: 25736791
J Cataract Refract Surg. 2005 Jan;31(1):156-62
pubmed: 15721708
J Glaucoma. 2006 Oct;15(5):364-70
pubmed: 16988597
Acta Ophthalmol Scand. 2006 Apr;84(2):206-9
pubmed: 16637838
J Cataract Refract Surg. 2005 Jan;31(1):146-55
pubmed: 15721707
Invest Ophthalmol Vis Sci. 2007 Jun;48(6):2540-4
pubmed: 17525182
Br J Ophthalmol. 2017 Mar;101(3):290-294
pubmed: 27474156
Arch Ophthalmol. 2003 Jan;121(1):48-56
pubmed: 12523884
Am J Ophthalmol. 1991 Apr 15;111(4):491-500
pubmed: 2012152
Ophthalmology. 2008 Jan;115(1):80-4
pubmed: 17573114
Ophthalmology. 2009 Jun;116(6):1125-33.e1-3
pubmed: 19376584
Int J Ophthalmol. 2012;5(1):102-7
pubmed: 22553765
J Glaucoma. 2012 Apr-May;21(4):209-13
pubmed: 21654511
Am J Ophthalmol. 2002 Jun;133(6):764-72
pubmed: 12036667
Ophthalmology. 1991 Mar;98(3):301-7
pubmed: 2023749
Surv Ophthalmol. 1993 Jul-Aug;38(1):1-30
pubmed: 8235993